Venous thromboembolism in patients with inflammatory bowel disease: focus on prevention and treatment.

Alfredo Papa, Gian Ludovico Rapaccini, Antonio Gasbarrini

Risultato della ricerca: Contributo in rivistaArticolo in rivistapeer review

32 Citazioni (Scopus)


Inflammatory bowel disease (IBD) patients have an increased risk of venous thromboembolism (VTE), which represents a significant cause of morbidity and mortality. The most common sites of VTE in IBD patients are the deep veins of the legs and pulmonary system, followed by the portal and mesenteric veins. However, other sites may also be involved, such as the cerebrovascular and retinal veins. The aetiology of VTE is multifactorial, including both inherited and acquired risk factors that, when simultaneously present, multiply the risk to the patient. VTE prevention involves correcting modifiable risk factors, such as disease activity, vitamin deficiency, dehydration and prolonged immobilisation. The role of mechanical and pharmacological prophylaxis against VTE using anticoagulants is also crucial. However, although guidelines recommend thromboprophylaxis for IBD patients, this method is still poorly implemented because of concerns about its safety and a lack of awareness of the magnitude of thrombotic risk in these patients. Further efforts are required to increase the rate of pharmacological prevention of VTE in IBD patients to avoid preventable morbidity and mortality.
Lingua originaleEnglish
pagine (da-a)3173-3179
Numero di pagine7
Stato di pubblicazionePubblicato - 2014


  • Inflammatory Bowel disease
  • Venous thromboembolism


Entra nei temi di ricerca di 'Venous thromboembolism in patients with inflammatory bowel disease: focus on prevention and treatment.'. Insieme formano una fingerprint unica.

Cita questo